Victory Capital Management Inc. Sells 16,141 Shares of Danaher Co. (NYSE:DHR)

Victory Capital Management Inc. trimmed its position in Danaher Co. (NYSE:DHR - Free Report) by 6.5% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 232,987 shares of the conglomerate's stock after selling 16,141 shares during the period. Victory Capital Management Inc.'s holdings in Danaher were worth $64,775,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of DHR. Vanguard Group Inc. lifted its stake in shares of Danaher by 7.4% during the 1st quarter. Vanguard Group Inc. now owns 60,107,030 shares of the conglomerate's stock valued at $15,009,928,000 after buying an additional 4,163,657 shares in the last quarter. Swedbank AB bought a new stake in Danaher during the first quarter worth about $676,545,000. TD Asset Management Inc grew its position in Danaher by 99.0% during the second quarter. TD Asset Management Inc now owns 1,358,706 shares of the conglomerate's stock valued at $339,473,000 after acquiring an additional 675,952 shares during the last quarter. Massachusetts Financial Services Co. MA raised its position in Danaher by 22.7% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 3,047,728 shares of the conglomerate's stock worth $761,475,000 after purchasing an additional 563,546 shares during the period. Finally, International Assets Investment Management LLC lifted its stake in Danaher by 40,196.5% in the third quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate's stock worth $119,539,000 after purchasing an additional 428,897 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Stock Performance

Shares of DHR traded down $8.50 during mid-day trading on Friday, hitting $230.88. 2,429,545 shares of the company traded hands, compared to its average volume of 2,746,040. The stock has a market cap of $166.76 billion, a price-to-earnings ratio of 45.00, a P/E/G ratio of 4.44 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The stock has a 50-day moving average price of $262.91 and a two-hundred day moving average price of $260.49. Danaher Co. has a 1 year low of $206.30 and a 1 year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company's quarterly revenue was up 3.1% on a year-over-year basis. During the same period last year, the firm earned $2.02 earnings per share. Equities analysts anticipate that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were given a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. Danaher's dividend payout ratio is currently 20.61%.

Insiders Place Their Bets

In other news, SVP Georgeann Couchara sold 952 shares of the firm's stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the sale, the senior vice president now directly owns 4,212 shares of the company's stock, valued at $1,130,374.44. This trade represents a 18.44 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 11.10% of the company's stock.

Analysts Set New Price Targets

Several research analysts have recently commented on DHR shares. Evercore ISI lifted their price objective on Danaher from $275.00 to $278.00 and gave the stock an "outperform" rating in a report on Tuesday, October 1st. KeyCorp upped their price target on shares of Danaher from $290.00 to $310.00 and gave the company an "overweight" rating in a report on Wednesday, October 23rd. Raymond James reduced their target price on Danaher from $310.00 to $300.00 and set an "outperform" rating on the stock in a research note on Wednesday, October 23rd. The Goldman Sachs Group raised their target price on shares of Danaher from $225.00 to $250.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 24th. Finally, Wolfe Research raised Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 price objective on the stock in a research report on Thursday, October 31st. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, Danaher currently has a consensus rating of "Moderate Buy" and a consensus price target of $287.16.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.